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Clearance of cerebrospinal fluid from the sacral
spine through lymphatic vessels
Qiaoli Ma1, Yann Decker2, Andreas Müller3, Benjamin V. Ineichen4, and Steven T. Proulx1,5
The pathways of circulation and clearance of cerebrospinal fluid (CSF) in the spine have yet to be elucidated. We have recently
shown with dynamic in vivo imaging that routes of outflow of CSF in mice occur along cranial nerves to extracranial lymphatic
vessels. Here, we use near-infrared and magnetic resonance imaging to demonstrate the flow of CSF tracers within the spinal
column and reveal the major spinal pathways for outflow to lymphatic vessels in mice. We found that after intraventricular
injection, a spread of CSF tracers occurs within both the central canal and the spinal subarachnoid space toward the caudal end
of the spine. Outflow of CSF tracers from the spinal subarachnoid space occurred predominantly from intravertebral regions
of the sacral spine to lymphatic vessels, leading to sacral and iliac LNs. Clearance of CSF from the spine to lymphatic vessels
may have significance for many conditions, including multiple sclerosis and spinal cord injury.
Introduction
There has been a recent surge of interest in the anatomical
pathways and physiology of cerebrospinal fluid (CSF) circulation
and outflow. Traditional concepts such as an immune privilege
of the central nervous system (CNS) and the absorption of CSF by
arachnoid villi have been challenged by several findings that
have highlighted an intimate role for the lymphatic system in
these processes (Aspelund et al., 2015; Louveau et al., 2015;
Engelhardt et al., 2017; Ma et al., 2017). A better understanding of
the function of the lymphatic system in the clearance of CSF has
relevance for many diseases, such as multiple sclerosis, neuro-
degenerative disorders, and hydrocephalus (Bakker et al., 2016;
Da Mesquita et al., 2018; Louveau et al., 2018; Hsu et al., 2019).
In our previous studies, we have found using injections of
inert macromolecular tracers into the lateral ventricle or cis-
ternamagna of mice that a bulk flow of tracers proceeds through
the basal cisterns to the lymphatic outflow pathways from the
skull (Ma et al., 2017, 2019). Consistent with previous studies,
CSF outflowwas found to occur within sheaths of exiting cranial
nerves to reach extracranial lymphatic vessels (McComb, 1983;
Bradbury and Cserr, 1985; Koh et al., 2005). Despite previous
reports to the contrary (Courtice and Simmonds, 1951), we found
no evidence for CSF outflow directly to blood of inert tracers,
even of low molecular weight (Ma et al., 2017). This led to the
concept that outflow of CSF occurs through lymphatic vessels
rather than to dural venous sinuses.
CSF has direct communication between the cranial and spinal
compartments of the CNS through continuity of the subarach-
noid space (SAS) at the foramen magnum. In addition, CSF
freshly produced by the choroid plexuses has access to the spine
through the central canal (CC) through an aperture on the floor
of the fourth ventricle. The direction of flow of CSF in either the
spinal SAS (Ishibashi, 1959; Di Chiro, 1966; Davson and Segal,
1996) or the CC (Bradbury and Lathem, 1965; Milhorat et al.,
1991; Cifuentes et al., 1992; Liu et al., 2018) is controversial.
Most of these studies were performed under anesthetized, im-
mobilized conditions, which limits CSF circulation (Ma et al.,
2019), or involved direct injections of tracers into the intrathe-
cal space, which may artificially induce nonphysiological tracer
distribution.
Several different CSF outflow pathways from the spine have
been proposed. These include flow through arachnoid villi to
spinal veins (Elman, 1923; Welch and Pollay, 1963; Kido et al.,
1976), routes along spinal nerve roots to epidural lymphatics
(Iwanow, 1928; Brierley and Field, 1948), and routes through the
arachnoid layer of the spinal meninges to dural lymphatics
(Zenker et al., 1994; Antila et al., 2017). Previous groups have
estimated that 16–25% of total CSF outflow may occur from the
spine (Marmarou et al., 1975; Bozanovic-Sosic et al., 2001; Asgari
et al., 2017). Others have suggested that spinal outflow pathways
to lymphatic vessels are not active under normal conditions and
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that pathways through the cranial outflow routes must be
blocked and/or that CSF pressures need to be elevated to pro-
duce outflow (Miura et al., 1998; Voelz et al., 2007).
Thus, it is clear at this point that several fundamental questions
remain unanswered regarding the circulation and outflow of CSF
in the spine. Therefore, in this study we used noninvasive near-
infrared and magnetic resonance imaging (MRI) methods after
infusions of macromolecular tracers at minimal rates and volumes
into the lateral ventricle of mice to examine the circulation of CSF
in the spinal column and identify the major spinal outflow path-
ways.We demonstrate the existence of CSFmovement toward the
caudal end of the spine through both the CC and spinal SAS to
lymphatic vessels draining the sacral region of the spine.
Results and discussion
Flow of tracers infused into the lateral ventricle occurs down
the CC to the sacral spine
We first aimed to evaluate the distribution of 40-kD pegylated
near-infrared IRDye680 (P40D680) tracer (Proulx et al., 2017) in
the spine 60 min after intracerebroventricular (i.c.v.) infusion.
Two areas of the spine that we defined as thoracic and sacral re-
gions had apparent high tracer signals (Fig. 1, A and B). Due to the
curvature of the spine, which made these particular regions more
accessible to near-infrared imaging, it was not immediately clear if
the tracer had spread to the sacral region through the spinal SAS
or directly through the CC from the ventricles. To evaluate this
question, we employed a noninvasive dynamic imaging approach.
Starting at 5 min after infusion, one group of mice was imaged at
the thoracic region, while another group was imaged at the sacral
region (Fig. 1 C and Videos 1 and 2). Surprisingly, the sacral region,
despite its distance from the lateral ventricle infusion site, ex-
hibited an enhancement of signal starting at an average of 17.0 ±
2.3 min after infusion that was significantly faster than the initial
enhancement of 23.7 ± 5.5 min at the thoracic region (Fig. 1 D),
implying tracer transport down the CC.
As the entrance of the CC exists at the floor of the fourth
ventricle, infusions of tracer into the lateral ventricle but not the
cisterna magna should lead to tracer transport to the caudal
spine (Bradbury and Lathem, 1965). To test this, we compared
the P40D680 tracer signals at the sacral region of spine between
mice in which tracer was infused i.c.v. or into the cisterna
magna (i.c.m.; Fig. S1). Signals at the sacral region were signif-
icantly higher in the i.c.v. group compared with the i.c.m. group
(i.c.v. 1,855 ± 874 vs. i.c.m. 374 ± 187 counts, P < 0.0001). No
significant differences were apparent in the thoracic region,
indicating that tracers have access to the SAS of the upper spine
through either injection route (i.c.v. 7,231 ± 2,543 vs. i.c.m.
5,555 ± 3,600 counts, P = 0.388). We next aimed to provide
histological evidence of tracer within the CC of the spinal cord
after i.c.v. injection. Since P40D680 is not amenable to fixation,
we used Evans blue (EB) dye, which can also be assessed using
its fluorescence on spinal cord sections. 30 min after infusion,
EB was clearly apparent in the CC of the thoracic spinal cord
(Fig. 1 E). EB was also obvious in the SAS at this level of the
spine. At the lumbar region, EB could still be detected in the CC,
albeit with much weaker fluorescence (Fig. 1 F). This is likely
due to its low molecular weight, as EB easily diffuses into the
spinal parenchyma through the ependymal lining of the CC,
similar to our previous observations at the brain ventricles (Ma
et al., 2017). Together, these data indicate that a directional flow
of CSF occurs within the CC from the ventricular system to the
caudal end of the spine.
Tracer accumulates at intervertebral regions in the sacral
region of the spine
We have previously shown that mice that were allowed to re-
cover from anesthesia after infusion of tracers exhibited dra-
matically accelerated CSF dynamics (Ma et al., 2019). Therefore,
we speculated that a similar experimental approach may lead to
insights into CSF circulation in the spine. We infused P40D680
i.c.v. and allowed the mice to either recover from isoflurane
anesthesia (awake group) or maintained them on a heating pad
under anesthesia (isoflurane group). Experiments were also
performed in a third group of mice anesthetized with ketamine/
medetomidine (ket/med group). By varying the amount of time
after the i.c.v. infusion (15, 30, 60, and 90 min), we examined
how the dynamics of tracer distribution were altered between
the awake and anesthetized conditions.
We first assessed the signals of the tracer within the thoracic
region of the spine (Fig. 2, A and B). In mice allowed to awaken,
the tracer spread to this region in greater quantity at early time
points compared with ket/med-anesthetized mice. At later time
points, the tracer signals decreased in the awake mice, indicat-
ing that the tracer was being cleared from the thoracic SAS. In
ket/med-anesthetized mice, the tracer signals were first ap-
parent at 30min and then increased over time, indicating slower
CSF dynamics under these conditions. Isoflurane-anesthetized
mice demonstrated an intermediate pattern of tracer dynamics,
with signals increasing up to 60 min before declining at 90 min.
Using this approach to examine the sacral region of the spine
(Fig. 2 C), several interesting observations were made. First, the
initial pattern of tracer signal exhibited focal accumulations in
the regions between vertebrae. At later time points, the number
of intervertebral regions containing tracer increased, with more
enhanced regions found in the awake mice compared with
anesthetized groups (Fig. 2 D). On examination of the mean
fluorescent signals at the sacral region over time (Fig. 2 E), no
significant differences were found at early time points between
the three groups. Signals continued to increase in this region over
time in all three groups of mice; however, signals in isoflurane-
anesthetized mice were significantly higher than both the awake
and ket/med-anesthetized groups at 90 min, indicating increased
accumulation of tracer in this region under these conditions. Fi-
nally, obvious tracer-filled vessel-like structures that were most
apparent in awake mice were seen emerging from the interver-
tebral regions, which led us to examine the potential CSF outflow
pathways from the spine in detail.
Tracers clear through lymphatic vessels at the caudal end of
the spine to reach sacral and iliac LNs
To demonstrate lymphatic outflow pathways from the spine,
we imaged Prox1-GFP mice that were awake for 60 or 90 min
after P40D680 i.c.v. infusion. On the dorsal aspect of the spine,
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tracer-filled Prox1-GFP+ lymphatic vessels emerged from the in-
tervertebral regions (Fig. 3 A) and drained into afferent-collecting
lymphatic vessels of sacral LNs. On the ventral side, we identified
collecting lymphatic vessels along the axis of the spine from the
sacral efflux sites draining tracer in a rostral direction toward
the caudal mesenteric and/or iliac LNs (Fig. 3 B). Tracer within
the efferent-collecting lymphatic vessels of the sacral LNs also
drained to the iliac LNs, indicating that this LN group may be
especially important for drainage of CSF from the spine. In other
regions of the spine, minor presence of tracer in Prox1-GFP+
lymphatic vessels was occasionally detectable at the dorsal lum-
bar region (Fig. S2).More frequently, tracer-filled vessels emerged
from the dorsal sacral spine and tracked further caudally to the tail
(Fig. S2). These lymphatic vessels then reversed course and
drained to the inguinal LNs. A close examination of several other
regions along the spine did not reveal any further sites of lym-
phatic outflow. Schemes of the anatomical routes of lymphatic
outflow from the sacral spine are shown in Fig. 3, C and D.
Tracer outflow to spine-draining LNs is minor in comparison to
outflow to cranial-draining LNs
We compared the average tracer signals within cranial-draining
(mandibular and deep cervical) and spine-draining (iliac and
caudal mesenteric) LNs at 60 min in the ket/med-anesthetized
Figure 1. A rapid flow of tracers occurs down the CC to the sacral spine. (A) Schematic of spine (lateral view). (B) Composite image of the dorsal aspect of
the spine demonstrating enhanced tracer signal in the thoracic and sacral regions 1 h after i.c.v. infusion of P40D680. Scale bar, 2 mm. (C) Representative signal
dynamics of P40D680 tracer spread to the thoracic (black) and sacral (blue) regions after i.c.v. infusion. (D) Initial time of P40D680 signal enhancement to the
thoracic and sacral regions from the i.c.v. infusion site. Data are mean ± SD and representative of two independent experiments (n = 5 each group, two-tailed
Student’s t test; *, P < 0.05). (E) Infusions of 0.6% EB i.c.v. were performed, and mice were sacrificed at 30 min. Representative section from the thoracic spinal
cord showing the anatomic features from the green autofluorescence (AF) channel and demonstrating EB fluorescence signal in the CC, as well as on the pia
mater lining the SAS. Scale bars, 200 µm. (F) Representative section from the lumbar spinal cord demonstrating EB in the CC, with no obvious EB fluorescence
apparent in the SAS. Scale bars, 200 µm. Representative of three independent experiments.
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and awake groups (Fig. 4 A). In ket/med-anesthetized mice, the
tracer signals within the spine-draining LNs were barely above
background levels and far below the levels seen in the cranial-
draining LNs (Fig. 4 B). Although lymphatic outflow was
increased in awake mice with higher signals within the spine-
draining LNs compared with ket/med-anesthetized mice
(awake 2,837 ± 1,105 vs. ket/med 732 ± 601 counts, P < 0.0057),
the tracer signals were still slight in comparison to the levels
found in the cranial-draining LNs. We conclude that the
proportion of CSF draining through this route is far below the
level that drains along the cranial nerves to the mandibular and
deep cervical LN basins.
MRI validation of spinal CSF distribution and sacral lymphatic
outflow after i.c.v. infusion
Finally, we aimed to confirm our findings with MRI. We de-
veloped a method to visualize both the ventricular system and
the entire spinal column in mice within one three-dimensional
Figure 2. Distribution of tracers within the thoracic and sacral spine under awake and anesthetized conditions. (A) Representative pictures of tracer
within the thoracic region of the spine after sacrifice at 15, 30, 60, and 90 min after P40D680 infusion into the right lateral ventricle of anesthetized (isoflurane
and ket/med) and awake group mice. Scale bars, 1 mm. (B) Quantification of fluorescence intensity in the thoracic region at the different time points.
(C) Representative pictures of tracer within the sacral region of the spine. Scale bars, 1 mm. (D) Quantification of the number of tracer-enhanced segments
between vertebrae at the different time points in anesthetized and awake mice. (E) Quantification of fluorescence intensity in the sacral region at the different
time points in anesthetized and awake mice. Data are mean ± SD and representative of two independent experiments (n = 5 each group, one-way ANOVA with
Tukey post hoc test; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
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(3D) scan and to perform infusions of contrast agents into the
lateral ventricle through an implanted cannula while animals
were positioned in the magnet. This allowed us to collect a
baseline scan and then initiate a low-rate infusion (0.1 µl/min
over the course of 60 min) of Gadospin D while performing
scans every 6 min under isoflurane anesthesia.
Using this protocol, we found evidence of contrast agent flow
down the CC, with simultaneous spreading of the contrast agent
to the spinal SAS (Figs. 5 A and S3). This method also allowed 3D
dynamic visualization of a lateral and dorsal spread of contrast
agent over time in the sacral intervertebral regions (Fig. 5, B and
C). We were able to confirm lymphatic outflow to both sacral
and iliac LNs (Fig. 5, A and C; Fig. S3; and Video 3). No lymphatic
outflow pathways from other regions of the spine were appar-
ent, although a slow diffusion of contrast agent along cervical
nerve roots was visualized (Fig. 5 A). Finally, a delayed en-
hancement of Gadospin D in the bladder (Fig. S3) is consistent
with lymphatic outflow of CSF (Ma et al., 2017). In sum, the MRI
data has supported the concept of a caudal circulation of CSF in
the spine to sites of lymphatic outflow in the sacral region.
Figure 3. Tracers clear through lymphatic vessels at the caudal end of the spine. (A) Representative pictures of P40D680 tracer within Prox1-GFP+
lymphatic vessels in the dorsal aspect of the sacral spine. Images were acquired 60 min after P40D680 i.c.v. infusion in awake group mice. Scale bars, 1 mm
(upper row); 2 mm (lower row). (B) Representative pictures of P40D680 tracer within Prox1-GFP+ lymphatic vessels running parallel along the ventral aspect of
the lumbar spine. Scale bars, 1 mm. Data are representative of three independent experiments. (C) Schematic of lymphatic vessel routing from dorsal aspect of
the caudal spine to sacral LNs. A route along subcutaneous lymphatic vessels from the base of the tail to inguinal LNs is also typically observed. (D) Schematic
of lymphatic vessel routing on ventral aspect of the caudal spine to caudal mesenteric and iliac LNs.
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In this study, we have elucidated several aspects of CSF cir-
culation in the spine using bulk flow tracers and imaging in
mice. We found that a directional flow of CSF occurs through the
CC from the ventricles to the caudal end of the spine and that
under both awake and anesthetized conditions, a cranial-to-
caudal movement of tracer also exists within the spinal SAS.
This leads to tracer accumulation at intervertebral regions in the
sacral spine, where outflow of CSF occurs through lymphatic
vessels.
This study has provided strong evidence for a normal flow of
CSF to the caudal aspect of the spine within the CC in mice. The
direction of the flow of CSF within the CC is a controversial
topic, as conflicting data have been published in the past
(Bradbury and Lathem, 1965; Milhorat et al., 1991; Cifuentes
et al., 1992; Liu et al., 2018). Our conclusion of a caudally di-
rected flow is in close agreement with Bradbury and Lathem
(1965) using rabbits and subsequent work in guinea pigs and
rats (Nakayama, 1976; Cifuentes et al., 1992). We found that the
tracer within the CC was able to access the sacral SAS as early as
15 min after infusion. Dorsal outlets for the fluid in the CC with
connections from the filum terminale internum to the SAS have
been identified in the sacral spine in rats, rabbits, guinea pigs,
and rhesus monkeys (Leduc et al., 1956; Bradbury and Lathem,
1965; Nakayama, 1976). In humans, a normal flow within this
anatomic space is often paid little heed, as it is believed that CC is
occluded after the third decade of life (Saker et al., 2016). This is
despite the well-known association between dilated CCs and the
development of syringomyelia (Gardner and Goodall, 1950;
Williams and Bentley, 1980).
The accepted driving forces for pulsatile CSF motion, respi-
ration and arterial pulse (O’Connell, 1943; Du Boulay et al., 1972;
Dreha-Kulaczewski et al., 2015), are not thought to exert a di-
rectional flow in the spine but instead to produce to-and-fro
movements of fluid. In our study, tracer cleared from the SAS of
the thoracic region in the awake and isoflurane-anesthetized
mice at later time points, with a strong increase in signals at
the sacral region at these same time points. Evidence for a
caudal-directed movement of CSF has been previously shown in
cats and monkeys (Grundy, 1962; Post et al., 1974). At this point,
we cannot completely rule out that the tracer reaches the spinal
SAS due to an acute rise in intracranial pressure during the
bolus infusion. However, even under conditions of a low-rate
(0.1 µl/min) infusion as performed during the MRI study, we
were able to demonstrate a caudal movement of contrast agent
in the spinal SAS.
Another major reason for the lack of acceptance for a direc-
tional flux of CSF in the spinal column is that there has been no
confirmed anatomical route for outflow from this compartment
of the CNS. Similar to the case with cranial arachnoid villi,
in vivo physiological evidence for CSF efflux to spinal veins is
lacking. Our results demonstrating a lymphatic outflow are in
agreement with several previous studies that have shown evi-
dence of tracers within spine-draining lymphatic vessels or LNs
(Iwanow, 1928; Galkin, 1930; Brierley and Field, 1948; Woollam
Figure 4. Tracer outflow to spine-draining
LNs is minor in comparison to outflow to
cranial-draining LNs. (A) Representative pic-
tures of tracer within deep cervical, mandibular,
and iliac/caudal mesenteric LN groups 60 min
after P40D680 i.c.v. infusion in ket/med and
awake mice. Dashed lines were drawn using
Prox1-GFP signals to indicate the location of LNs
with low P40D680 signal. Scale bars, 1 mm. (B)
Fluorescence intensity of the three LN groups at
60 min in ket/med and awake mice. Data are
mean ± SD and representative of two indepen-
dent experiments (n = 5 each group, one-way
ANOVA with Tukey’s post hoc analysis; **, P <
0.01; ***, P < 0.001).
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and Millen, 1958; Kida et al., 1993; Zenker et al., 1994; Boulton
et al., 1996; Miura et al., 1998; Voelz et al., 2007; Kwon et al.,
2017). These earlier investigators typically needed to employ
multiple injections of tracer, to inject high volumes directly into
the spinal SAS, or to block cranial outflow pathways to dem-
onstrate spinal outflow to lymphatics. Here, we show with low-
volume injections of tracer or contrast agent into the lateral
ventricle that a spinal CSF outflow through lymphatics can be
detected under more physiological conditions. This is in agree-
ment with the classic work in rabbits from Brierley and Field
(1948) using India ink and work from the group of Miles John-
ston (Boulton et al., 1996) in sheep using radiolabeled albumin.
The detailed anatomy at the sites of outflow to lymphatics
still needs elucidation. We speculate that the tracer-enriched
regions between vertebral segments may represent outflow
pathways at the subarachnoid angle (McCabe and Low, 1969). At
these locations where the spinal nerve roots exit the spinal
column, the arachnoid membrane forms a cul-de-sac at the root
ganglion. In early studies, India ink particles were found to ac-
cumulate at the cul-de-sac, with some particles found within
nearby epidural lymphatics (Iwanow, 1928; Brierley and Field,
1948). It has been proposed that at this particular site the
arachnoid barrier is lacking, providing potential access to lym-
phatic vessels located within the spinal dura mater or in epidural
tissue (Zenker et al., 1994). While these networks of lymphatic
vessels have been found to be particularly enriched at the cervical
and thoracic regions (Antila et al., 2017; Jacob et al., 2019 Preprint;
Miura et al., 1998), we could detect CSF outflow predominantly at
the caudal end. Both postmortem near-infrared fluorescence
imaging in Prox1-GFP mice and in vivo MRI indicated a lack of
significant outflow at other spinal locations. We speculate that
outflow pathways at the end of the spine would provide a po-
tential sink of lower pressure that would help to distribute CSF
from its site of production within the ventricles down the length
of the spinal column. In humans, an outflow at the caudal end
would perhaps be even more logical because our species spends a
significant amount of time in an upright position.
Finally, we demonstrate that the proportion of CSF draining
from the spine appears to be limited compared with outflow
from the skull. It has been found that CSF outflow resistance
Figure 5. Spinal CSF distribution and sacral
lymphatic outflow as detected with MRI. Vi-
sualization of tracer spread after low-rate i.c.v.
infusion (0.1 µl/min) of Gadospin D solution at 25
mM; data acquired with a series of T1-weighted
MRI measurements (3D time-of-flight gradient
recalled echo sequence). (A) Representative
maximum-intensity projection of enhanced ventric-
ular system and spinal column. (B and C) Repre-
sentative signal dynamics of Gadospin D contrast
agent spread to the caudal end of the spine in
sagittal (B) and coronal (C) planes. Enhancement of
signal in the sacral LN (SLN) is detectable as early as
30 min. Data are representative of n = 5 mice and
three independent experiments.
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from the spine was far greater than that from the cranium, in-
dicating that the spinal outflow pathways are less open to bulk
flow (Bozanovic-Sosic et al., 2001). Supporting this concept, we
found that tracer signals were still increasing in the sacral spine
at 90 min in awake mice despite our earlier data indicating that
up to 80% of the infused tracer has already reached the systemic
blood under these conditions (Ma et al., 2019). Surprisingly,
accumulation of tracers at 90 min in the sacral region was even
greater in isoflurane-anesthetized mice. It is likely that this ac-
cumulation at the sites of spinal outflow under isoflurane rep-
resents a reduced clearance by lymphatics. Decreased lymphatic
clearance may be due to the known effects of tissue immobili-
zation during anesthesia on initial lymphatic uptake (Proulx
et al., 2017) and inhibitory effects of isoflurane on the contrac-
tility of collecting lymphatic vessels (Bachmann et al., 2019).
Despite the slow relative turnover of CSF in the spine, it is still
evident that a normal CSF circulation occurs within this com-
partment of the CNS toward lymphatic outflow pathways.
The presence of caudally directed movement of CSF in the
spinal column to sacral lymphatic outflow routes still needs to be
confirmed in humans. This fluid pathwaymay have implications
for diseases such as multiple sclerosis and syringomyelia, as well
as after spinal cord injury. In addition, elucidation of the routes
of circulation of CSF may lead to optimized strategies for CNS
drug delivery and an improved interpretation of clinical sam-
pling of CSF constituents from lumbar puncture.
Materials and methods
Mice
Femalewild-typemice (Janvier) and Prox1-GFP reportermice on
the C57BL/6J background were kept under specific pathogen–
free conditions and used for experimental studies at the age of
2–3 mo. Prox1-GFP mice were backcrossed to a C57BL/6J back-
ground for ≥10 generations. All mouse experiments were ap-
proved by the Kantonales Veterinäramt Zürich (license numbers
185/13, 161/16, and 245/17) and by the Landesamt für Gesundheit
und Verbraucherschutz, Saarbruecken, Germany (license num-
ber 31/2018), and performed following the regulations of the
Swiss Federal Welfare Act.
Infusion of tracers into lateral ventricle or cisterna magna
Mice were anesthetized (80 mg/kg ketamine and 0.2 mg/kg
medetomidine or with 2% isoflurane) and positioned in a ster-
eotaxic frame (RWD) and maintained at 37°C body temperature
using a heating pad (Stoelting). A dental drill (RWD) was then
used to thin the skull at a position 0.95 mm lateral and 0.22 mm
caudal to the bregma. A 34G steel needle was inserted into the
right lateral ventricle 2.35 mm ventral to the skull surface. A
bolus of 2.5 µl of 200 µM P40D680 tracer (Proulx et al., 2013)
was infused at the speed of 1 µl/min with a syringe pump
(Stoelting). The needle was left in place for 2.5 min and then
slowly removed. Ex vivo analysis of brain sections was per-
formed as previously described to ensure proper tracer injection
into the lateral ventricle (Ma et al., 2017).
For cisterna magna infusion, a surgical procedure to access
this structure was performed as previously described (Ineichen
et al., 2017). After a small skin incision was made over the oc-
cipital bone/cervical spinal cord, the three covering muscle
layers were carefully dissected under a stereomicroscope using
fine forceps and scissors. The atlanto-occipital membrane was
then prepunctured using a 34G cannula, and the infusion can-
nula was inserted through this opening into the cisterna magna
to a depth of 250 µm. A droplet of histoacryl was added to the
interface of cannula and the atlanto-occipital membrane to avoid
reflux of CSF during the infusion. Overall, 5 µl of 100 µM
P40D680 tracer was infused at the speed of 1 µl/min. After the
infusion, the cannula was left in place for 10 min to avoid
backflow. After withdrawal of the cannula, a droplet of histo-
acryl was added to prevent CSF fistula.
In vivo dynamic imaging of tracer flow in the spine
For noninvasive imaging of the spine, fur overlying the thoracic
or sacral region of the spine was removed with a razor and
depilation cream before tracer infusion. After lateral ventricle
tracer infusion, the mice were immediately positioned under a
Zeiss StereoLumar.V12 stereomicroscope with AxioVision soft-
ware (Carl Zeiss) and a Photometrics Evolve 512 camera (Pho-
tometrics) in a prone position on a heating pad (37°C). The
autofluorescence signal on the GFP channel was used to position
the region of the spine at 24× zoom. Dynamic imaging was ini-
tiated 5 min after completion of the i.c.v. infusion by acquisition
of a sequence of images (one image every 15 s for 55 min) with a
Cy5 filter set to monitor the near-infrared signals of the tracers.
Exposure time and camera gain settings were 200 ms and 200,
respectively.
To assess the tracer transport to the different regions of the
spine, a circular region of interest (ROI) with a radius of 500 µm
was placed over the spine on the acquired videos. A table of
fluorescence intensity in counts versus time was generated us-
ing the Measure Profile function and was exported into Micro-
soft Excel. Baseline intensity in counts was calculated as the
average signal of the lowest 10 consecutive imaging frames. This
baseline intensity was then subtracted from the fluorescence
intensity values to plot fluorescent signal enhancement versus
time in minutes. We then examined where the signal starts to
climb above this normalized zero value, which indicated the
arrival of the tracer at the ROI. To verify that the increase was
not due to normal fluctuations in the background signal, we
ensured that the signal increased over four consecutive frames.
The time point at which the signal increase started was recorded
as the transit time of the tracer.
Comparison of CSF dynamics during awake or
anesthesia conditions
At 20 min before lateral ventricle infusion, 0.1 mg/kg bupre-
norphine was injected subcutaneously. Mice were then anes-
thetized by intraperitoneal injection of 80 mg/kg ketamine and
0.2mg/kgmedetomidine (ket/med group) or by inhalation of 2%
isoflurane (awake and isoflurane groups) and fixed in a stereo-
taxic frame for lateral ventricle tracer infusion (as described
above). In the awake group, the mice were allowed to recover
(within 5 to 10 min after infusion) and were active for 15, 30, 60,
or 90min (n = 5 each time point). For the ket/med and isoflurane
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groups, the mice remained anesthetized for 15, 30, 60, or 90min
on a heating pad (37°C). At the designated times, mice were
overdosed by intraperitoneal injection of 400 mg/kg ketamine
and 1 mg/kg medetomidine for postmortem imaging.
Analysis of postmortem near-infrared tracer distribution
Images of P40D680 tracerwithin the CNS-draining LNs andwithin
the spinal column were acquired with a Zeiss AxioZoom V16 mi-
croscope and a QImaging OptiMOS sCMOS camera (QImaging)
combined with light-emitting diode illumination system pE-4000
(CoolLED) and ZEN 2 software (Carl Zeiss). Images of LNs were
acquired in situ at 25× and 200-ms exposure time. Since there
were no apparent differences in signal in the LNs on the injected
and contralateral sides, the average value of the nodes on each side
was used for statistical analysis. The thoracic and sacral regions of
the spine were imaged after removal of the skin at 15× and 200-ms
exposure time. The region of the thoracic image starts from the
junction point of the muscle spinalis and semispinalis thoracis and
muscle longissimus thoracis and extends in a caudal direction with
the spine in themiddle of the image. The region of the sacral region
image starts from the base of the tail and extends in a rostral di-
rection with the spine in the middle. For analysis of signal en-
hancement in the analyzed tissues, background signals were
subtracted based on the average signal of three uninjected mice.
Distribution of EB on spinal cord sections
A bolus of 2.5 µl of 0.6% EB (Sigma) was infused in the lateral
ventricle (as described above). After 30 min, the mouse was
sacrificed, and the spinal cord was carefully dissected out of the
spinal column and placed in 4% paraformaldehyde at 4°C for 48 h.
Sections at a thickness of 100 µm of spinal cord tissue from the
thoracic and lumbar regions were then cut with a vibratome
(Leica VT1000 S). Images were acquired with a Zeiss AxioZoom
V16 microscope and ZEN 2 software.
Dynamic contrast–enhanced MRI of the spine
20 min before the surgical procedure, mice were injected sub-
cutaneously with carprofen (5 mg/kg). Mice were anesthetized
by inhalation of 2% isoflurane and fixed in a stereotaxic frame.
Under this narcosis, the skull was thinned with a dental
drill, and a 28G, 2.5-mm-long MRI-compatible microcannula
(#328OP/PK/Spc; Plastics One) was inserted stereotactically
0.95 mm lateral and 0.22 mm caudal to the bregma and 2.50 mm
ventral to the skull surface. Before the infusion, animals were
transferred to a horizontal-bore 9.4-T animal scanner (BioSpec
Avance III 94/20; Bruker Biospin) with a BGA12S gradient system
and ParaVision 6.0.1 (Bruker Biospin). The infusion was per-
formed with a NanoJet syringe pump (Chemyx) pushing a 10-µl
Hamilton syringe attached to a 1.5-m PE line. At its opposite end,
the line was filled with a 10-µl solution of Gadospin D and con-
nected to the cannula. For whole-spine imaging, a 2-channel
transmit/16-channel receive array volume coil with an inner
diameter of 60 mm (Bruker Biospin) was used. To limit the size
of the pictures and acquisition time, only eight channels were
used. Imaging was performed with a 3D time-of-flight gradient
recalled echo sequence with repetition/echo time = 14.0/2.5 ms,
flip angle = 25°, matrix size = 600 × 216 × 216, field of view = 80.0 ×
28.8 × 28.8 mm, numerical aperture = 2, and t = 6 min 3 s. After
one acquisition, a solution of 6 µl Gadospin D at 25mMgadolinium
(nanoPET Pharma) was infused at a rate of 0.1 µl per min. A series
of ≥18 scans then continued until ≥108 min. 3D maximum-
intensity projection reconstructions were performed with Horos
(version 2.0.1, Horos Project). For signal intensity analysis, in
Horos software, ROIs were created manually around the sacral
spine, sacral LN, and bladder. ROIs were drawn on two sections
for each animal, and the signals from each of the anatomical ROIs
were averaged. For background determination, circular ROIs were
drawn outside the animal body.
Statistical analyses
Statistical analyses were performed with GraphPad Prism 7.
Graphs represent mean ± SD. Student’s t test was used to com-
pare two groups, and one-way ANOVA followed by the Tukey
multiple comparison test was used to compare three groups at
each time point. Other types of tests are indicated in the figure
legends. A P value <0.05 was considered statistically significant.
Online supplemental material
Fig. S1 demonstrates the differences in CSF tracer distribution
after either i.c.v. or i.c.m. infusion to the thoracic and sacral
regions of the spine under ket/med anesthesia. Fig. S2 shows
P40D680 tracer within additional lymphatic outflow pathways
from the lumbar and sacral regions of the spine. Fig. S3 shows
the distribution of MR contrast agent Gadospin D over time,
including apparent signal within the CC. Video 1 demonstrates
noninvasive near-infrared imaging of the thoracic region of the
spine after i.c.v. infusion of P40D680, showing signal en-
hancement in this region over time. Video 2 shows noninvasive
near-infrared imaging of the sacral region of the spine after i.c.v.
infusion of P40D680, showing an earlier signal enhancement in
this region. Video 3 is a 3D dynamic reconstruction of MRI of the
CSF contrast agent spread and outflow in the spine.
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